1315 Capital is a leading private investment firm that partners with medical technology, healthcare services, and specialty therapeutics companies to drive their growth. With over $965 million under management, 1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies. Their investment approach focuses on targeting markets where high-quality management teams can rapidly scale platform companies into large and important businesses that have a positive impact on patients, physicians, and the broader healthcare system.

What sets 1315 Capital apart is their operating team model, which combines financial and business development expertise with deep industry knowledge to support the growth of their portfolio companies. They also leverage their extensive network for management talent, advisors, deal sourcing, diligence, and board roles. With a diverse portfolio of companies in various healthcare sectors, 1315 Capital is dedicated to making a difference in the industry by investing in exceptional healthcare teams and companies